Giatron is indicated as a viscoelastic supplement or as a substitute for synovial fluid in human joints.
Composition: A pre-filled syringe of 2 ml contains:
Sodium Hyaluronate 30 mg.
Excipients: Sodium chloride, Water for injections.
Giatron is indicated for the symptomatic treatment of degenerative diseases of the synovial joints, such as osteoarthritis, in patients in whom non-pharmacological and simple analgesic treatment (e.g. with acetaminophen) is ineffective.
The actions of the Giatron product are: lubrication and mechanical support.
Dosage form: Solution for injection, Solution for intra-articular injection.
Dosage and directions for use:
Giatron must be administered only by qualified medical operators trained in the technique of intra-articular administration.
Giatron must be administered strictly intra-articular.
Do not administer intravenously.
Aseptic administration technique must be strictly followed.
